3iconcept medical solution

The healthcare industry is evolving rapidly, and one of the fastest-growing areas is drug device combination products . These innovative solutions bring together the therapeutic benefits of drugs with the precision and convenience of medical devices. From pre-filled insulin pens to drug-eluting stents, combination products are transforming patient care. But with innovation comes regulatory complexity—especially in Europe. Manufacturers must navigate both medicinal product and medical device regulations, making compliance a challenging yet crucial step. In this guide, we’ll break down everything you need to know about the European framework for drug-device combination products, offering clarity for businesses, manufacturers, and regulatory professionals. What Are Drug Device Combination Products? Drug device combination products are therapeutic products that integrate both a medicinal substance and a medical device. They are designed to work together as a single entity, ensuring sa...

Risk management plays a critical role in industries where product safety, compliance, and reliability are essential. In sectors like medical devices, pharmaceuticals, automotive, and aerospace, organizations must adopt systematic methods to identify, assess, and mitigate risks. Two widely recognized approaches are Failure Mode and Effects Analysis (FMEA) and iso 14971 , the international standard for medical device risk management. While both frameworks deal with risk, their focus, methodology, and applicability differ significantly. Understanding these differences helps businesses select the right strategy—or even integrate both—for their unique needs. What is FMEA? Failure Mode and Effects Analysis (FMEA) is a structured approach used to anticipate potential failures in a product, process, or system before they occur. It systematically examines possible failure modes, their causes, and the consequences of those failures. By assigning severity, occurrence, and detection rankings, team...